Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NuGen Medical Devices Inc ( (TSE:NGMD) ) has shared an announcement.
NuGen Medical Devices Inc. has announced the development of a new needle-free injection system featuring internal cartridge technology, which simplifies drug administration and enhances patient safety. This innovation integrates a sterile internal insulin cartridge into their proprietary needle-free autoinjector, eliminating the need for external connectors and manual filling. Under the leadership of CEO Liang Lin, the company has expanded its R&D, quality, and clinical teams to support this development, with plans for clinical investigations and prototype development within six months, aiming for scaled manufacturing and commercialization by early 2026.
More about NuGen Medical Devices Inc
NuGen Medical Devices Inc. is a company specializing in the development of next-generation needle-free devices for subcutaneous drug delivery. Its flagship product, the InsuJet™ system, is approved in 42 countries and aims to improve the lives of millions of people with diabetes worldwide.
Average Trading Volume: 115,875
Technical Sentiment Signal: Sell
Current Market Cap: C$12.03M
Find detailed analytics on NGMD stock on TipRanks’ Stock Analysis page.